Molecular cardiovascular imaging using scintigraphic methods

European Radiology

Volumn 17, Issue 6, 2007, Pages 1422-1432

  Stegger, Lars ^a   Schäfers, Klaus ^a   Kopka, Klaus ^a   Wagner, Stefan ^a   Hermann, Sven ^a   Kies, Peter ^a   Law, Marilyn ^a   Schober, Otmar ^a   Schäfers, Michael ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Cardiovascular; Molecular imaging; PET; Scintigraphic; SPECT

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; 1 FLUORO 3 (2 NITRO 1 IMIDAZOLYL) 2 PROPANOL F 18; 3 (2 FLUOROETHYL)SPIPERONE F 18; 3 HYDROXYEPHEDRINE C 11; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE; 4 (3 TERT BUTYLAMINO 2 HYDROXYPROPOXY) 2 BENZIMIDAZOLONE C 11; AMMONIA N 13; ANTHRACYCLINE; BASIC FIBROBLAST GROWTH FACTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CGS 27023A; CGS 27023A I 123; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOPAMINE 2 RECEPTOR; ENDOTHELIN; FIALURIDINE; FLUORODEOXYGLUCOSE F 18; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LIPOCORTIN 5 TC 99M; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; METHYLQUINUCLIDINYLBENZILATE C 11; N ACETYLENDOTHELIN 1 [6-21][11,15 ALANINE]; N ACETYLENDOTHELIN 1 [6-21][11,15 ALANINE] F 18; PENTETREOTIDE; PENTETREOTIDE IN 111; RADIOISOTOPE; RUBIDIUM CHLORIDE RB 82; SACCHARIC ACID TC 99M; TETROFOSMIN TC 99M; THALLIUM CHLORIDE TL 201; THYMIDINE KINASE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULOTROPIN; VASCULOTROPIN RECEPTOR 1;

ANGIOGENESIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYSTEM; CELL MIGRATION; CELL PROLIFERATION; GENE EXPRESSION; HEART INFARCTION; HEART INNERVATION; HEART MUSCLE METABOLISM; HEART MUSCLE PERFUSION; HEART SCINTISCANNING; HEART VENTRICLE FIBRILLATION; HUMAN; HYPOXIA; ISOTOPE LABELING; MOLECULAR IMAGING; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STEM CELL;

ANIMALS; AUTONOMIC NERVOUS SYSTEM; CARDIOVASCULAR DISEASES; GENE EXPRESSION PROFILING; HEART; HUMANS; MOLECULAR BIOLOGY; MOLECULAR PROBE TECHNIQUES; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 34248663519     PISSN: 09387994     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00330-006-0541-6     Document Type: Article

References (70)

1. Blumgart HL, Yens OC (1927) Studies on the velocity of blood flow: I. The method utilized. J Clin Invest 4:1-13
2. Schäfers KP, Stegger L, Barnard C et al (2005) ECG-triggered high-resolution positron emission tomography: A breakthrough in cardiac molecular imaging of mice. Eur J Nucl Med Mol Imaging 32:383
3. Assmann G, Cullen P, Schulte H (2002) Simple scoring scheme for calculating the risk of acute coronary events based on the 10-year follow-up of the prospective cardiovascular Münster (PROCAM) study. Circulation 105:310-315
4. Vanzetto G, Ormezzano O, Fagret D, Comet M, Denis B, Machecourt J (1999) Long-term additive prognostic value of thallium-201 myocardial perfusion imaging over clinical and exercise stress test in low to intermediate risk patients: Study in 1137 patients with 6-year follow-up. Circulation 100:1521-1527
5. Hachamovitch R, Berman DS, Kiat H et al (1996) Exercise myocardial perfusion SPECT in patients without known coronary artery disease: incremental prognostic value and use in risk stratification. Circulation 93:905-914
6. Beller GA, Bergmann SR (2004) Myocardial perfusion imaging agents: SPECT and PET. J Nucl Cardiol 11:71-86
7. Germano G, Kiat H, Kavanagh PB et al (1995) Automatic quantitation of ejection fraction from gated myocardial perfusion SPECT. J Nucl Med 36:2138-2147
8. Stegger L, Biedenstein S, Schäfers KP, Schober O, Schäfers MA (2001) Elastic surface contour detection for the measurement of ejection fraction in myocardial perfusion SPET. Eur J Nucl Med 28:48-55
9. Sharir T, Germano G, Kavanagh PB et al (1999) Incremental prognostic value of post-stress left ventricular ejection fraction and volume by gated myocardial perfusion single photon emission computed tomography. Circulation 100:1035-1042
10. Schelbert HR (2002) 18 F-deoxyglucose and the assessment of myocardial viability. Semin Nucl Med 32:60-69
11. Stegger L, Schäfers KP, Flögel U et al (2005) Monitoring left ventricular dilation in mice with PET. J Nucl Med 46:1516-1521
12. Tamaki N, Morita K, Kuge Y, Tsukamoto E (2000) The role of fatty acids in cardiac imaging. J Nucl Med 41:1525-1534
13. Schäfers M, Dutka D, Rhodes CG et al (1998) Myocardial presynaptic and postsynaptic autonomic dysfunction in hypertrophic cardiomyopathy. Circ Res 82:57-62
14. Wichter T, Schäfers M, Rhodes CG et al (2000) Abnormalities of cardiac sympathetic innervation in arrhythmogenic right ventricular cardiomyopathy: Quantitative assessment of presynaptic norepinephrine reuptake and postsynaptic beta-adrenergic receptor density with positron emission tomography. Circulation 101:1552-1558
15. Schäfers M, Lerch H, Wichter T et al (1998) Cardiac sympathetic innervation in patients with idiopathic right ventricular outflow tract tachycardia. J Am Coll Cardiol 32:181-186
16. Kies P, Wichter T, Schäfers M et al (2004) Abnormal myocardial presynaptic norepinephrine recycling in patients with Brugada syndrome. Circulation 110:3017-3022
17. de Jong RM, Willemsen AT, Slart RH et al (2005) Myocardial beta-adrenoceptor downregulation in idiopathic dilated cardiomyopathy measured in vivo with PET using the new radioligand (S)-[11C]CGP12388. Eur J Nucl Med Mol Imaging 32:443-447
18. Wagner S, Law MP, Riemann B et al (2006) Synthesis of a F-18-labelled high affinity beta1-adrenoceptor PET radioligand based on ICI 89, 406. J Label Compd Radiopharm 49:177-195
19. Law MP, Osman S, Pike VW et al (2000) Evaluation of [11C]GB67, a novel radioligand for imaging myocardial alpha 1-adrenoceptors with positron emission tomography. Eur J Nucl Med 27:7-17
20. Inoue H, Zipes DP (1987) Results of sympathetic denervation in the canine heart: Supersensitivity that may be arrhythmogenic. Circulation 75:877-887
21. Inobe Y, Kugiyama K, Miyagi H et al (1997) Longlasting abnormalities in cardiac sympathetic nervous system in patients with coronary spastic angina: Quantitative analysis with iodine 123 metaiodobenzylguanidine myocardial scintigraphy. Am Heart J 134:112-118
22. Wilson RF, Laxson DD, Christensen BV, McGinn AL, Kubo SH (1993) Regional differences in sympathetic reinnervation after human orthotopic cardiac transplantation. Circulation 88:165-171
23. Yamada T, Shimonagata T, Fukunami M et al (2003) Comparison of the prognostic value of cardiac iodine-123 metaiodobenzylguanidine imaging and heart rate variability in patients with chronic heart failure: A prospective study. J Am Coll Cardiol 41:231-238
24. Paul M, Schäfers M, Kies P et al (2006) Impact of sympathetic innervation on recurrent life-threatening arrhythmias in the follow-up of patients with idiopathic ventricular fibrillation. Eur J Nucl Med Mol Imaging 33:866-870
25. Nakata T, Wakabayashi T, Kyuma M, Takahashi T, Tsuchihashi K, Shimamoto K (2004) Cardiac metaiodobenzylguanidine activity can predict the long-term efficacy of angiotensin-converting enzyme inhibitors and/or beta-adrenoceptor blockers in patients with heart failure. Eur J Nucl Med Mol Imaging 32:186-194
26. Lekakis J, Prassopoulos V, Athanassiadis P, Kostamis P, Moulopoulos S (1996) Doxorubicin-induced cardiac neurotoxicity: Study with iodine 123-labeled metaiodobenzylguanidine scintigraphy. J Nucl Cardiol 3:37-41
27. Delforge J, Le Guludec D, Syrota A et al (1993) Quantification of myocardial muscarinic receptors with PET in humans. J Nucl Med 34:981-991
28. Le Guludec D, Cohen-Solal A, Delforge J, Delahaye N, Syrota A, Merlet P (1997) Increased myocardial muscarinic receptor density in idiopathic dilated cardiomyopathy: An in vivo PET study. Circulation 96:3416-3422
29. Falk E, Shah PK, Fuster V (1995) Coronary plaque disruption. Circulation 92:657-671
30. Greenland P, LaBree L, Azen SP, Doherty TM, Detrano RC (2004) Coronary artery calcium score combined with Framingham score for risk prediction in asymptomatic individuals. JAMA 29:210-215
31. Rudd JH, Warbourton EA, Fryer TD et al (2002) Imaging atherosclerotic plaque inflammation with [18F]-fluorodeoxyglucose positron emission tomography. Circulation 105:2708-2711
32. Kopka K, Breyholz HJ, Wagner S et al (2004) Synthesis and preliminary biological evaluation of new radioiodinated MMP inhibitors for imaging MMP activity in vivo. Nucl Med Biol 31:257-267
33. Schäfers M, Riemann B, Kopka K et al (2004) Scintigraphic imaging of matrix metalloproteinase activity in the arterial wall in vivo. Circulation 109:2554-2559
34. Furumoto S, Takashima K, Kubuta K, Ido T, Iwata R, Fukuda H (2003) Tumor detection using 18 F-labeled matrix metalloproteinase-2 inhibitor. Nucl Med Biol 30:119-125
35. Breyholz H-J, Schäfers M, Wagner S et al (2005) C-5-disubstituted barbiturates as potential molecular probes for noninvasive matrix metalloproteinase imaging. J Med Chem 48:3400-3409
36. Kolodgie FD, Petrov A, Virmani R et al (2003) Targeting of apoptotic macrophages and experimental atheroma with radiolabeled annexin V: A technique with potential for noninvasive imaging of vulnerable plaque. Circulation 108:3134-3139
37. Kietselaer BL, Reutelingsperger CP, Heidendal GA et al (2004) Noninvasive detection of plaque instability with use of radiolabeled annexin A5 in patients with carotid-artery atherosclerosis. N Engl J Med 350:1472-1473
38. Hartung D, Sarai M, Petrov A et al (2005) Resolution of apoptosis in atherosclerotic plaque by dietary modification and statin therapy. J Nucl Med 46:2051-2056
39. Hofstra L, Liem IH, Dumont EA et al (2000) Visualisation of cell death in vivo in patients with acute myocardial infarction. Lancet 356:209-212
40. Narula J, Acio ER, Narula N et al (2001) Annexin-V imaging for noninvasive detection of cardiac allograft rejection. Nat Med 7:1347-1352
41. Mariani G, Villa G, Rossettin PF et al (1999) Detection of acute myocardial infarction by 99mTc labeled D-glucararic acid imaging in patients with acute chest pain. J Nucl Med 54:1832-1839
42. Inoue A, Yanagisawa M, Kimura S et al (1989) The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci USA 86:2863-2867
43. Iwasa S, Fan J, Shimokama T, Nagata M, Watanabe T (1999) Increased immunoreactivity of endothelin-1 and endothelin B receptor in human atherosclerotic lesions. A possible role in atherogenesis. Atherosclerosis 146:93-100
44. Johnström P, Harris NG, Fryer TD et al (2002) 18 F-Endothelin-I, a positron emission tomography (PET) radioligand for the endothelin receptor system: Radiosynthesis and in vivo imaging using microPET. Clin Sci 103:4S-8S
45. Dinkelborg LM, Duda SH, Hanke H, Tepe G, Hilger CS, Semmler W (1998) Molecular imaging of atherosclerosis using a technetium-99m-labeled endothelin derivative. J Nucl Med 39:1819-1822
46. Johnström P, Rudd JH, Richards HK et al (2006) Imaging endothelin ET(B) receptors using [18F]-BQ3020: In vitro characterization and positron emission tomography (microPET). Exp Biol Med 231:736-740
47. Livieratos L, Stegger L, Bloomfield PM, Schafers K, Bailey DL, Camici PG (2005) Rigid-body transformation of list-mode projection data for respiratory motion correction in cardiac PET. Phys Med Biol 50:3313-3322
48. Dawood M, Lang N, Jiang X, Schafers KP (2006) Lung motion correction on respiratory gated 3-D PET/CT images. IEEE Trans Med Imaging 25:476-485
49. Shelton ME, Dence CS, Hwang DR, Herrero P, Welch MJ, Bergmann SR (1990) In vivo delineation of myocardial hypoxia during coronary occlusion using fluorine-18 fluoromisonidazole and positron emission tomography: A potential approach for identification of jeopardized myocardium. J Am Coll Cardiol 16:477-485
50. Fujibayashi Y, Cutler CS, Anderson CJ et al (1999) Comparative studies of Cu-64-ATSM and C-11-acetate in an acute myocardial infarction model: ex vivo imaging of hypoxia in rats. Nucl Med Biol 26:117-121
51. Udelson JE, Dilsizian V, Laham RJ et al (2000) Therapeutic angiogenesis with recombinant fibroblast growth factor-2 improves stress and rest myocardial perfusion abnormalities in patients with severe symptomatic chronic coronary artery disease. Circulation 102:1605-1610
52. Henry TD, Rocha-Singh K, Isner JM et al (2001) Intracoronary administration of recombinant human vascular endothelial growth factor to patients with coronary aftery disease. Am Heart J 142:872-880
53. Giordano FJ, Ping P, McKirnan MD et al (1996) Intracoronary gene transfer of fibroblast growth factor-5 increases blood flow and contractile function in an ischemic region of the heart. Nat Med 2:534-539
54. Lu E, Wagner WR, Schellenberger U et al (2003) Targeted in vivo labeling of receptors for vascular endothelial growth factor: Approach to identification of ischemic tissue. Circulation 108:97-103
55. Haubner R, Wester H-J, Reuning U et al (1999) Radiolabeled aαvβ3 integrin antagonists: A new class of tracers for tumor targeting. J Nucl Med 40:1061-1071
56. Beer AJ, Haubner R, Sarbia M et al (2006) Positron emission tomography using [18F]Galacto-RGD identifies the level of integrin alpha(v)beta3 expression in man. Clin Cancer Res 12:3942-3949
57. Meoli DF, Sadeghi MM, Krassilnikova S et al (2004) Noninvasive imaging of myocardial angiogenesis following experimental myocardial infarction. J Clin Invest 113:1684-1691
58. Sadeghi MM, Krassilnikova S, Zhang J et al (2004) Detection of injury-induced vascular remodeling by targeting activated alpha V beta 3 integrin in vivo. Circulation 110:84-90
59. Zhang J, Krassilnikova S, Gharaei AA et al (2005) Alphavbeta3-targeted detection of arteriopathy in transplanted human coronary arteries: An autoradiographic study. FASEB J 19:1857-1859
60. Donahue JK, Kikuchi K, Sasano T (2005) Gene therapy for cardiac arrhythmias. Trends Cardiovasc Med 15:219-224
61. Wu JC, Inubushi M, Sundaresan G, Schelbert HR, Gambhir SS (2002) Positron emission tomography imaging of cardiac reporter gene expression in living rats. Circulation 106:180-183
62. Bengel FM, Anton M, Richter T et al (2003) Noninvasive imaging of transgene expression by use of positron emission tomography in a pig model of myocardial gene transfer. Circulation 108:2127-2133
63. Jacobs A, Voges J, Reszka R et al (2001) Positron-emission tomography of vector-mediated gene expression in gene therapy for gliomas. Lancet 358:727-729
64. MacLaren DC, Gambhir SS, Satyamurthy N et al (1999) Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals. Gene Ther 6:785-791
65. Miyagawa M, Beyer M, Wagner B et al (2005) Cardiac reporter gene imaging using the human sodium/iodide symporter gene. Cardiovasc Res 65:195-202
66. Chen IY, Wu JC, Min JJ et al (2004) Micro-positron emission tomography imaging of cardiac gene expression in rats using bicistronic adenoviral vector-mediated gene delivery. Circulation 109:1415-1420
67. Wu JC, Chen IY, Wang Y et al (2004) Molecular imaging of the kinetics of vascular endothelial growth factor gene expression in ischemic myocardium. Circulation 110:685-691
68. Orlic D, Kajstura J, Chementi S et al (2004) Bone marrow cells regenerate infarcted myocardium. Nature 428:664-668
69. Aicher A, Brenner W, Zuhayra M et al (2003) Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling. Circulation 107:2134-2139
70. Wu JC, Spin JM, Cao F et al (2006) Transcriptional profiling of reporter genes used for molecular imaging of embryonic stem cell transplantation. Physiol Genomics 25:29-38